arrangement for the Mixed-use project of THB 492 million, and (2) a decrease in net long-term loan of THB 133 million. Dusit Thani PCL Management Discussion and Analysis 2017 P a g e | 5 Shareholders’ Equity As
revenue (%) 27.31% 29.59% Performance Ratio Return on Equity (ROE) (%) 10.82% 10.63% Return on Assets (ROA) (%) 5.78% 5.57% Capital Structure and Debt Ratio Debt to Equity ratio (time) 0.84 0.86 Debt
management discussion and analysis http://maco.listedcompany.com/misc/mdna/20181106-maco- mdna-3q2018-en.pdf). Trans.Ad Group’s Shareholding Structure 81.65% Trans.Ad Group 89% 100% MACO Eye on Ads Trans.Ad
(%) 22.40% 27.31% Performance Ratio Return on Equity (ROE) (%) 8.32% 10.82% Return on Assets (ROA) (%) 4.24% 5.78% Capital Structure and Debt Ratio Debt to Equity ratio (time) 1.05 0.84 Debt Service Coverage
% Performance Ratio Return on Equity (ROE) (%) 9.20% 10.75% Return on Assets (ROA) (%) 4.80% 5.80% Capital Structure and Debt Ratio Debt to Equity ratio (time) 0.97 0.83 Debt Service Coverage ratio (DSCR) (time
27, 2017, CTBC Bank Company Limited has entered into the shareholder of the company amount of 7,544,961,342 shares or 35.6169% of the paid-up capital. As a result the current shareholders structure as
, 2017, CTBC Bank Company Limited has entered into the shareholder of the company amount of 7,544,961,342 shares or 35.6169% of the paid-up capital. As a result the current shareholders structure as
the new TFRS 16 – Lease of THB 7,416 million and increase in long- term loans. Shareholders’ Equity As of 30 June 2020, Shareholders’ Equity of THB 4,665 million, decreased by THB 1,240 million or 21.0
adoption of new financial reporting standards, the acquisition of a new subsidiary and the depreciation of the Thai Baht that affected the value of Company’s overseas assets • Net debt to equity ratio at the
overseas assets • Net debt to equity ratio at the end of 2Q 2020 stood at 0.98x, an increase from 0.48x on 31 December 2019 2Q 2020 SIGNIFICANT EVENTS Impacts of Coronavirus Disease 2019 (COVID–19) COVID-19